Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Facon

Showing results (11-20 of 301) with videos related to

Pageof 31
Sort By:
La Revue Du Praticien|March 22, 2006
[Prognostic factors and new treatments of multiple myeloma]Xavier Leleu, Valérie Coiteux, Thierry Facon
Clinical Advances in Hematology & Oncology : H&O|June 24, 2008
Recent phase III trials in the frontline treatment of multiple myeloma: evaluating their impact on community practiceJesus SanMiguel, Thierry Facon, Michele Cavo
Blood Reviews|June 14, 2008
Frontline treatment of multiple myeloma in elderly patientsPhilippe Moreau, Cyrille Hulin, Thierry Facon
Blood|April 4, 2015
Frontline therapy of multiple myelomaPhilippe Moreau, Michel Attal, Thierry Facon
Hematology/Oncology Clinics of North America|September 13, 2014
Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell TransplantationPhilippe Moreau, Cyrille Hulin, Thierry Facon
Blood|January 24, 2023
How I treat multiple myeloma in geriatric patientsThierry Facon, Xavier Leleu, Salomon Manier
Cancer|September 24, 2005
Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignanciesHeinz Ludwig, David Khayat, Giuseppe Giaccone, et al.
Blood Cancer Journal|March 11, 2026
Toward a cure for multiple myeloma within a decadeMohamad Mohty, Florent Malard, Thierry Facon, et al.
Blood Cancer Journal|August 12, 2024
A roadmap towards improving outcomes in multiple myelomaMohamad Mohty, Thierry Facon, Florent Malard, et al.
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Pageof 31

Showing results (11-20 of 301) with videos related to

Sort By:
Pageof 31
La Revue Du Praticien|March 22, 2006
[Prognostic factors and new treatments of multiple myeloma]Xavier Leleu, Valérie Coiteux, Thierry Facon
Clinical Advances in Hematology & Oncology : H&O|June 24, 2008
Recent phase III trials in the frontline treatment of multiple myeloma: evaluating their impact on community practiceJesus SanMiguel, Thierry Facon, Michele Cavo
Blood Reviews|June 14, 2008
Frontline treatment of multiple myeloma in elderly patientsPhilippe Moreau, Cyrille Hulin, Thierry Facon
Blood|April 4, 2015
Frontline therapy of multiple myelomaPhilippe Moreau, Michel Attal, Thierry Facon
Hematology/Oncology Clinics of North America|September 13, 2014
Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell TransplantationPhilippe Moreau, Cyrille Hulin, Thierry Facon
Blood|January 24, 2023
How I treat multiple myeloma in geriatric patientsThierry Facon, Xavier Leleu, Salomon Manier
Cancer|September 24, 2005
Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignanciesHeinz Ludwig, David Khayat, Giuseppe Giaccone, et al.
Blood Cancer Journal|March 11, 2026
Toward a cure for multiple myeloma within a decadeMohamad Mohty, Florent Malard, Thierry Facon, et al.
Blood Cancer Journal|August 12, 2024
A roadmap towards improving outcomes in multiple myelomaMohamad Mohty, Thierry Facon, Florent Malard, et al.
Leukemia|June 20, 2020
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma NetworkGordon Cook, Alessandra Larocca, Thierry Facon, et al.
Pageof 31